logo
Strides Pharma's US arm acquires four drugs to bolster portfolio

Strides Pharma's US arm acquires four drugs to bolster portfolio

Strides Pharma Science said that its step-down wholly owned subsidiary in the US, Stride Pharma Inc, has acquired four approved ANDAs for the US Market from Nostrum Laboratories, Inc., USA.
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs (Urinary Tract Infections), Pain Management, Allergy Symptoms and Attention Deficit Disorder (ADD/ ADHD) and Narcolepsy.
Two (out of the four) ANDAs acquired are commercial products and is expected to be launched within 12 months. With access to these products, Strides will expand its portfolio of niche and difficult to manufacture products.
The cumulative market size for the acquired portfolio is around $57 million as per IQVIA data of 2025. Total consideration for acquisition of the said ANDAs is $ 2.075 million (Rs 17.6 crore).
Strides Pharma Science is global pharmaceutical company headquartered in Bangalore, India. It develops and manufactures wide range of niche and technically complex pharmaceutical products
The companys consolidated net profit jumped 77.1% to Rs 87.95 crore on 14.7% increase in net sales to Rs 1153.67 crore in Q3 FY25 over Q3 FY24.
The counter declined 1.61% to end at Rs 652.55 on Tuesday, 29 April 2025.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SMEs in Pune and Pimpri-Chinchwad seek govt intervention to cushion blow of Trump's tariffs on India
SMEs in Pune and Pimpri-Chinchwad seek govt intervention to cushion blow of Trump's tariffs on India

Indian Express

time7 minutes ago

  • Indian Express

SMEs in Pune and Pimpri-Chinchwad seek govt intervention to cushion blow of Trump's tariffs on India

Small-scale industries in Pune and Pimpri-Chinchwad have urged the Central and Maharashtra governments to take immediate steps to mitigate the negative effects of the 25 per cent tariffs on imports from India proposed by United States President Donald Trump. Industrialist Arun Firodia has called for a drastic reduction in electricity charges as well as interest rates to ensure the sustainability of engineering exports. Firodia, who is the chairman of Kinetic Group, said drastic steps like a reduction in electricity rates have to be taken to keep up the competitiveness of Indian engineering goods in the US and world market. 'Our industries should get electricity at Rs 2 per unit,' he said. At present, industrial units purchase electricity at Rs 8.32 per unit in the state, which is one of the highest in the country. 'The government must take steps to increase the purchase power of the consumer by reducing domestic taxation,' he said. Last week, Trump announced a 25 per cent tariff on Indian imports from August 7, alongside an additional but unspecified 'penalty' for India's defence and energy imports from Russia. Small- and medium-scale industries in Pune and Pimpri Chinchwad are mostly vendors and sub-vendors of the automotive industry in the district. In Pimpri-Chinchwad alone, more than 5,000 small and medium-scale industries employ over 3-4 lakh people in various engineering operations. SMEs are also involved in exports directly or indirectly. Precious stones, engineering goods, pharmaceutical, textiles are some of the major exports from the country to the USA. Abhay Bhor, president of the Federation of Small Scale Industries Association in Pimpri-Chinchwad, urged both the state and Central government to take urgent steps to mitigate the effects of the tariff. 'Engineering goods, pharmaceuticals, electronics and industrial packaging units are based on the US export markets for their survival. The tariff, Bhor said, will result in loss of jobs as well as closure of the industries. 'Most industries are going through a rough patch with this tariff; it can really be a body blow to the industries,' he said. Bhor requested Chief Minister Devendra Fadnavis to immediately interfere to ensure this crisis is resolved. 'The sector requires handholding and the chief minister must take urgent steps to help the sector,' he said.

Nippon India mutual fund opens Leh branch to boost border inclusion
Nippon India mutual fund opens Leh branch to boost border inclusion

Business Standard

time7 minutes ago

  • Business Standard

Nippon India mutual fund opens Leh branch to boost border inclusion

In a bid to deepen financial inclusion, Nippon Life India Asset Management Ltd has opened a branch in Leh and is looking to expand its presence in border areas, its CEO Sundeep Sikka said. With this, Nippon Life India Asset Management (NAM India) -- promoted by Japan's Nippon Life Insurance Company -- becomes the only asset management company in the country to establish a physical presence in such a high-altitude region. This marks NAM India's 167th branch and its presence in 266 pin codes across the country. Explaining the reason for opening the branch, Sikka said Ladakh, a Union Territory known for its breathtaking landscapes, has seen a surge in tourism and economic activity in recent years. However, the region's financial landscape remains relatively underdeveloped, with limited access to a diverse range of investment products. The average assets under management (AAUM) in Jammu & Kashmir and Ladakh stood at Rs 10,844 crore as of June 2025, accounting for less than 0.14 per cent of India's total mutual fund assets. In contrast, India's overall mutual fund AAUM reached a staggering Rs 74.80 lakh crore during the same period. "With a presence in Leh, Ladakh, Nippon India Mutual Fund aims to bridge the financial literacy gap, develop a healthy mutual fund ecosystem and offer local residents the opportunity to participate in the Indian capital markets," Sikka said. The company plans to open more branches in India's border regions that often face limited access to formal financial services, the chief executive said. However, he did not specify a timeline for the rollout of additional branches. At present, Nippon India Mutual Fund is present in all districts and 97 per cent of PIN codes across India. When asked about the challenges of operating in such regions, Sikka pointed out that while many residents have a decent income, there is a clear lack of awareness about formal investment avenues. "People here are earning well, but often end up putting their money into unregulated or informal products due to limited financial literacy," he said. Highlighting the need for investor education as a top priority, he said the company's first objective is to build trust and understanding around mutual funds. "We are also exploring the launch of simple, easy-to-understand products tailored to the needs of first-time investors in these areas," he noted. About the company's future expansion strategy, Sikka said Nippon India Mutual Fund is focused on strengthening its digital infrastructure, noting that nearly 70 per cent of new investors are now coming through online channels. At the same time, the company remains committed to expanding its physical presence, recognising that on-ground branches play a key role in building trust. Additionally, he revealed plans to launch a Specialised Investment Fund (SIF) aimed at offering more targeted investment solutions.

Maxivision opens 10 Super Speciality Eye hospitals in Chennai
Maxivision opens 10 Super Speciality Eye hospitals in Chennai

News18

time31 minutes ago

  • News18

Maxivision opens 10 Super Speciality Eye hospitals in Chennai

Agency: PTI Last Updated: Chennai, Aug 3 (PTI) Eye care provider Maxivision has launched 10 super specialty eye hospitals across the city marking its entry into the state capital. Maxivision currently operates eye care facilities in Tiruchirappalli, Madurai, Salem, Thanjavur, Kumbakonam, Perambalur. With the launch of Chennai operations, Maxivision has committed investments of Rs 100 crore to expand in all districts and towns across Tamil Nadu over the next two years. Cricket legend Mahendra Singh Dhoni inaugurated a super specialty eye hospital in the presence of Maxivision Eye Hospitals Group Chairman and Managing Director GSK Velu along with senior officials at an event, here, on Saturday. The hospitals, which are currently operational across the city, are equipped with robotic femto-laser cataract surgery, advanced diagnostics for retina, cornea and glaucoma, diabetic retinopathy treatment and corneal transplantation among others. This strategic expansion directly addresses the city's escalating burden of cataract, glaucoma and lifestyle driven vision disorders, Maxivision said in a press release on Sunday. Commenting on the expansion in the metro, Velu said, 'It is long-term overdue and we are pleased to arrive in marks a strategic step forward in expanding our footprint in the high-demand, high-potential market of Chennai." The Chennai launch by MS Dhoni is aligned with the long-term vision to build a strong, decentralised ophthalmic infrastructure that can effectively address the growing burden of cataract, retina, glaucoma and several other vision disorders, he said. 'With this expansion, Maxivision reinforces its commitment to shaping the future of eye care delivery in Chennai and Tamil Nadu, " he noted. Last year, Maxivision Super Specialty Eye Hospitals signed a Memorandum of Understanding with the Government of Tamil Nadu committing Rs 400 crore investments to launch its project 'Velicham' (Light) which aims to offer affordable eye care to underserved regions besides generating employment and enhancing ophthalmic training and research. PTI VIJ VIJ ROH view comments First Published: August 03, 2025, 16:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store